Key facts
- This page summarizes Lucy Lu's Form 4 filing for Fortress Biotech, Inc. (FBIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2025, 16:20.
Lucy Lu - 01 Jan 2025 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)
- Reporting relationship
- Director
- Issuer ticker
- FBIO
- Reported as of
- 01 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2025, 16:20:13 UTC
- Prior SEC filing
- 02 Oct 2024
- Next SEC filing
- 08 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Samuel Berry, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Lucy Lu filed Form 4 for Fortress Biotech, Inc. (FBIO) on 03 Jan 2025.
Change
- Previous filing in this sequence was filed on 02 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FBIO
transaction
common stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +49,383
- Change %
- +415%
- Price
- $0.000000
- Shares after
- 61,273
- Date
- 01 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer.
Footnote F2
Total holdings include 58,047 shares underlying deferred restricted stock units.